Reply To: Nivolumab dosing and Medicare

[Anonymous]

Wow – I had not heard about Medicare reimbursement. We have not yet started the 480 mg monthly dosing, but if reimbursement is an issue, our practice will probably delay doing that. As far as seeing the patients monthly, I think that will vary on physician preference. For a very busy practice, I could certainly see some physicians liking the once monthly visits/treatments, but on the other hand, this might not be good for the patient that likes/wants to be seen frequently or is possibly not one to report AEs unless at a visit.